Curr Opin Biotechnol. 2013 Aug;24(4):724-34. doi: 10.1016/j.copbio.2013.05.003. Epub 2013 Jun 11.
Current opinion in biotechnology
Ken Donaldson, Craig A Poland
PMID: 23768801 DOI: 10.1016/j.copbio.2013.05.003
The analysis of nanoparticle (NP) hazard is currently a major research pre-occupation for particle toxicologists since there is a pressing requirement for a comprehensive understanding of nanoparticle hazard because of the wide spectrum of NP varying in composition, shape and size that require testing for risk assessment. The Biologically Effective Doses (BEDs) of nanoparticles, the dose entity that drives toxicity include charge, solubility, contaminants, shape and the ability to translocate from the site of deposition in the lungs. We point out here that all of these modes of toxicity are relevant and described for conventional pathogenic particles. There is no evidence that particles below 100nm, the threshold definition of a NP, show any step-change in their hazard meaning that there is no evidence of novel 'nano-specific hazard'. Therefore conventional particle toxicology data are useful and relevant to the determination of the nanoparticle hazard. Emphasis away from 'nano-specific effects' and the availability of hazard data from conventional particles will focus limited resource towards a full understanding of the NP hazard. This will lead to improved ability to identify and test for their effects and measure their toxicokinetics and so contribute to their risk assessment.
Copyright © 2013 Elsevier Ltd. All rights reserved.
